Intrua Financial’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,284
Closed -$200K 372
2022
Q1
$200K Sell
3,284
-3,436
-51% -$205K 0.04% 369
2021
Q4
$443K Sell
6,720
-267
-4% -$17.1K 0.08% 239
2021
Q3
$451K Sell
6,987
-49,155
-88% -$3.14M 0.08% 227
2021
Q2
$585K Buy
56,142
+40,740
+265% +$2.36M 0.14% 147
2021
Q1
$925K Buy
15,402
+5,898
+62% +$327K 0.23% 94
2020
Q4
$519K Buy
9,504
+900
+10% +$47K 0.23% 89
2020
Q3
$461K Buy
8,604
+222
+3% +$10.8K 0.23% 97
2020
Q2
$413K Buy
+8,382
New +$358K 0.16% 135

Other funds holding IHI

Intrua Financial's IHI Position: Q2 2022 in Review

Intrua Financial sold out of iShares US Medical Devices ETF (IHI) in Q2 2022, closing a stake of 3,284 shares — an estimated $200K sold.

Intrua Financial first reported a position in IHI in Q2 2020 and held it in 8 quarters. The position peaked at $925K in Q1 2021. 593 funds tracked by Wall St. Rank hold IHI as of Q2 2022.

  • Intrua Financial reported no remaining iShares US Medical Devices ETF position as of Q2 2022 after selling out during the quarter.
  • Intrua Financial sold 3,284 iShares US Medical Devices ETF shares in Q2 2022, an estimated $200K.
  • Intrua Financial first reported a position in iShares US Medical Devices ETF in Q2 2020 and held it in 8 quarters.
  • Intrua Financial's iShares US Medical Devices ETF position peaked at $925K in Q1 2021.
  • 593 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2022.

Based on Intrua Financial's 13F filing for Q2 2022, filed 12 Aug 2022.